Allogene Therapeutics Inc (ALLO)

Other Income/Expenses (Net)

$4.24M

Quarterly · Period ending: · USD

ALLO logo

ALLO Other Income/Expenses (Net)

Latest reported$4.24M
ALLO Quarterly Other Income/Expenses (Net) ($0.00 → $4.24M)
High-resolution chart · PNG

ALLO other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Allogene Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
4,243,000
3,485,000
3,594,000
3,501,000
5,876,000
5,458,000
994,000
5,481,000
5,073,000
4,504,000
-4,083,000
709,000
1,308,000
-876,000
1,527,000
-659,000
1,807,000
142,000
-975,000
-516,000
93,000
186,000
792,000
1,843,000
2,184,000
3,203,000
3,390,000
4,309,000
4,559,000
4,825,000
2,420,000
-21,310,000
110,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.